Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00467584 · ClinicalTrials.gov registry record · Phase 3
Aspirin for Treatment of Multiple Sclerosis-Related Fatigue
A Phase 3 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 3
- Development phase
- 62
- Enrollment target
NCT00467584: Clinical Trial Phase 3 study, sponsored by Mayo Clinic.
NCT00467584 is a Phase 3 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00467584, a Phase 3 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 62 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether aspirin is effective for treatment of fatigue caused by multiple sclerosis (MS).
Interventions
- DRUG Placebo
- DRUG High Dose Aspirin (1300 mg/day)
- DRUG Low Dose Aspirin (162 mg/day)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2007-07 |
| Est. Completion | 2013-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00467584
The ClinicalTrials.gov registry entry for NCT00467584 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00467584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00467584 about?
NCT00467584 is a clinical study titled "Aspirin for Treatment of Multiple Sclerosis-Related Fatigue". The purpose of this study is to determine whether aspirin is effective for treatment of fatigue caused by multiple sclerosis (MS).
What is the current status of trial NCT00467584?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 62 participants. The study started on 2007-07. Estimated completion is 2013-09.
What interventions are being tested in trial NCT00467584?
The interventions under investigation include: Placebo (DRUG), High Dose Aspirin (1300 mg/day) (DRUG), Low Dose Aspirin (162 mg/day) (DRUG).
Who is sponsoring clinical trial NCT00467584?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.